EUVIMEDEUVIMED entdecken
Scoping Review

The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis

Nilasha Ghosh, Bridget Jivanelli, Nina Couette, Namrata Singh, Marie Kostine, Alexa Simon Meara, David F L Liew

Rheumatic Disease Clinics of North America · 2024-05 · 50 (2) · 325-335

DOI: 10.1016/j.rdc.2024.02.006 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Rheumatic Disease Clinics of North America, 2024-05. Verfasst von Nilasha Ghosh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA. Electronic address: ghoshn@hss.edu. Hauptthemen laut MEDLINE: Arthritis, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an immune-related adverse event that can occur as a result of receiving ICIs for cancer treatment. Thus far, ICI-IA has been described variably in the literature, in part due to varying presentations that evolve over time, as well as a lack of standardized definitions and classification. This scoping review aggregates various descriptions of ICI-IA, highlighting the most prominent attributes of ICI-IA from categories such as symptoms, signs, imaging, and laboratory findings as well as discussing potential mimic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArthritisImmune Checkpoint InhibitorsHumansNeoplasms

Stichwörter der Autor:innen

CancerImmune checkpoint inhibitorsImmune-related adverse eventsImmunotoxicityInflammatory arthritis

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA. Electronic address: ghoshn@hss.edu.
  • Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA.
  • Department of Rheumatology, Rheumatology Care Center, Genesis Healthcare System, 2525 Maple Avenue, Zanesville, OH 43701, USA.
  • Division of Rheumatology, Department of Medicine, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.
  • Department of Rheumatology, Bordeaux University Hospital, 311 Président Wilson Boulevard, Bordeaux 33200, France.
  • Division of Oncology, Department of Medicine, The Ohio State University Wexner Medical Center, 460 West 10th Avenue, Columbus, OH 43210, USA.

Zitieren

APA

Ghosh, N., Jivanelli, B., Couette, N., Singh, N., Kostine, M., Simon Meara, A., & Liew, D. F. L. (2024). The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis. Rheumatic Disease Clinics of North America, 50(2), 325-335. https://doi.org/10.1016/j.rdc.2024.02.006

Vancouver

Ghosh N, Jivanelli B, Couette N, Singh N, Kostine M, Simon Meara A, et al. The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis. Rheumatic Disease Clinics of North America. 2024;50(2):325-335. doi:10.1016/j.rdc.2024.02.006

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Nilasha and Jivanelli, Bridget and Couette, Nina and Singh, Namrata and Kostine, Marie and Simon Meara, Alexa and Liew, David F L},
  title = {The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis},
  journal = {Rheumatic Disease Clinics of North America},
  year = {2024},
  volume = {50},
  number = {2},
  pages = {325--335},
  doi = {10.1016/j.rdc.2024.02.006}
}
Kostenlos starten →